Lars Fruergaard Jørgensen is a Danish businessman and has been the chief executive of Novo Nordisk since January 2017. He is the chairman of the European Federation of Pharmaceutical Industries and Associations. From Wikipedia
Lars Fruergaard Jørgensen's departure comes as the company faces declining shares and rising competition, but Novo Nordisk reaffirms its 2025 financial targets.
